Literature DB >> 11244343

Comparison of hypotonic and isotonic solutions containing sodium hyaluronate on the symptomatic treatment of dry eye patients.

V Papa1, P Aragona, S Russo, A Di Bella, P Russo, G Milazzo.   

Abstract

This study was designed to compare the efficacy of two artificial tears both containing hyaluronic acid but differing in their osmolarity. A multicentric double-masked, crossover clinical trial was performed in which 158 subjects were randomized to receive either hypotonic or isotonic artificial tears up to 6 times a day. Both treatments were effective in improving signs and symptoms to a similar extent. No adverse events were reported. It was concluded that hypotonic and isotonic eye drops are comparable for the symptomatic treatment of patients suffering from dry eye syndrome. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244343     DOI: 10.1159/000050842

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  12 in total

Review 1.  [Dry eye. An update on epidemiology, diagnosis, therapy and new concepts].

Authors:  F Schirra; K W Ruprecht
Journal:  Ophthalmologe       Date:  2004-01       Impact factor: 1.059

2.  Cytoprotective effect of hyaluronic acid and hydroxypropyl methylcellulose against DNA damage induced by thimerosal in Chang conjunctival cells.

Authors:  Juan Ye; Huina Zhang; Han Wu; Changjun Wang; Xin Shi; Jiajun Xie; Jinjing He; Jun Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-24       Impact factor: 3.117

3.  Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye.

Authors:  Pasquale Aragona; Vincenzo Papa; Antonio Micali; Marcello Santocono; Giovanni Milazzo
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

4.  TRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells.

Authors:  Zan Pan; Zheng Wang; Hua Yang; Fan Zhang; Peter S Reinach
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

5.  Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye.

Authors:  Michael E Johnson; Paul J Murphy; Mike Boulton
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-28       Impact factor: 3.117

6.  Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjögren's syndrome patients.

Authors:  P Aragona; G Di Stefano; F Ferreri; R Spinella; A Stilo
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

7.  Novel Artificial Tears Containing Cross-Linked Hyaluronic Acid: An In Vitro Re-Epithelialization Study.

Authors:  Arianna Fallacara; Silvia Vertuani; Giacomo Panozzo; Alessandra Pecorelli; Giuseppe Valacchi; Stefano Manfredini
Journal:  Molecules       Date:  2017-11-30       Impact factor: 4.411

8.  Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye.

Authors:  Jun Woong Moon; Hyun Joo Lee; Ki Chul Shin; Won Ryang Wee; Jin Hak Lee; Mee Kum Kim
Journal:  Korean J Ophthalmol       Date:  2007-12

9.  Use of preservative-free hyaluronic acid (Hylabak(®)) for a range of patients with dry eye syndrome: experience in Russia.

Authors:  Vladimir Vsevolodovich Brjesky; Yury Fedorovich Maychuk; Alexey Vladimirovich Petrayevsky; Peter Gerrievich Nagorsky
Journal:  Clin Ophthalmol       Date:  2014-06-18

10.  Cationic Thiolated Poly(aspartamide) Polymer as a Potential Excipient for Artificial Tear Formulations.

Authors:  Mária Budai-Szűcs; Gabriella Horvát; Barnabás Áron Szilágyi; Benjámin Gyarmati; András Szilágyi; Szilvia Berkó; Piroska Szabó-Révész; Giuseppina Sandri; Maria Cristina Bonferoni; Carla Caramella; Judit Soós; Andrea Facskó; Erzsébet Csányi
Journal:  J Ophthalmol       Date:  2016-05-23       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.